Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


14.08.2017

1 AJNR Am J Neuroradiol
2 Br J Cancer
1 Clin Cancer Res
9 Eur J Cancer
1 J Clin Oncol
2 J Neurooncol
2 J Neuropathol Exp Neurol
1 J Neurosurg
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. KEIL VC, Warmuth-Metz M, Reh C, Enkirch SJ, et al
    Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.
    AJNR Am J Neuroradiol. 2017 Aug 10. doi: 10.3174/ajnr.A5313.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. ABDUL RAHIM SA, Dirkse A, Oudin A, Schuster A, et al
    Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.
    Br J Cancer. 2017 Aug 10. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  3. SHI C, Ren L, Sun C, Yu L, et al
    miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. WANG G, Shen J, Sun J, Jiang Z, et al
    Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/beta-catenin Signaling.
    Clin Cancer Res. 2017 Aug 8. pii: clincanres.0774.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  5. KHATUA S, Ramaswamy V, Bouffet E
    Current therapy and the evolving molecular landscape of paediatric ependymoma.
    Eur J Cancer. 2017;70:34-41.
    PubMed     Text format     Abstract available

  6. MANIAS KA, Gill SK, MacPherson L, Foster K, et al
    Magnetic resonance imaging based functional imaging in paediatric oncology.
    Eur J Cancer. 2017;72:251-265.
    PubMed     Text format     Abstract available

  7. FOSSARD G, Ferlay C, Nicolas-Virelizier E, Rey P, et al
    Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Eur J Cancer. 2017;72:12-19.
    PubMed     Text format     Abstract available

  8. GEORGAKIS MK, Kalogirou EI, Liaskas A, Karalexi MA, et al
    Anthropometrics at birth and risk of a primary central nervous system tumour: A systematic review and meta-analysis.
    Eur J Cancer. 2017;75:117-131.
    PubMed     Text format     Abstract available

  9. EL-GALALY TC, Villa D, Michaelsen TY, Hutchings M, et al
    The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
    Eur J Cancer. 2017;75:195-203.
    PubMed     Text format     Abstract available

  10. STACCHIOTTI S, Saponara M, Frapolli R, Tortoreto M, et al
    Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
    Eur J Cancer. 2017;76:84-92.
    PubMed     Text format     Abstract available

  11. DONIA M, Kimper-Karl ML, Hoyer KL, Bastholt L, et al
    The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.
    Eur J Cancer. 2017;74:89-95.
    PubMed     Text format     Abstract available

  12. TWELVES C, Cortes J, O'Shaughnessy J, Awada A, et al
    Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
    Eur J Cancer. 2017;76:205-215.
    PubMed     Text format     Abstract available

  13. GAUDY-MARQUESTE C, Dussouil AS, Carron R, Troin L, et al
    Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
    Eur J Cancer. 2017;84:44-54.
    PubMed     Text format     Abstract available


    J Clin Oncol

  14. PAGLIARO LC
    Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    J Clin Oncol. 2017;35:1036-1040.
    PubMed     Text format     Abstract available


    J Neurooncol

  15. WEGENSCHIMMEL B, Leiss U, Veigl M, Rosenmayr V, et al
    Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study.
    J Neurooncol. 2017 Aug 4. doi: 10.1007/s11060-017-2582.
    PubMed     Text format     Abstract available

  16. GE M, Zhuang Y, Zhou X, Huang R, et al
    High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
    J Neurooncol. 2017 Aug 5. doi: 10.1007/s11060-017-2590.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  17. SCHWEIZER Y, Meszaros Z, Jones DTW, Koelsche C, et al
    Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
    J Neuropathol Exp Neurol. 2017;76:655-664.
    PubMed     Text format     Abstract available

  18. PRATT D, Pittaluga S, Palisoc M, Fetsch P, et al
    Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:697-708.
    PubMed     Text format     Abstract available


    J Neurosurg

  19. KOTECHA R, Miller JA, Venur VA, Mohammadi AM, et al
    Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    J Neurosurg. 2017 Aug 11:1-10. doi: 10.3171/2017.1.JNS162797.
    PubMed     Text format     Abstract available


    Oncogene

  20. GUERRERO PA, Tchaicha JH, Chen Z, Morales JE, et al
    Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  21. GLADILIN E
    Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.
    PLoS One. 2017;12:e0170953.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: